[FDA Press Release, April 29, 2024 ]Today , the U.S. Food and Drug Administration took action aimed at helping to ensure the safety and effectiveness of laboratory developed tests, or LDTs, which are used in a growing number of health care decisions and about which concerns have been raised for many years. Continue reading
Author Archive: AZBio
AdvaMed Statement on the Release of FDA Rule on Laboratory-Developed Tests
April 29, 2024, WASHINGTON, D.C. – Today, AdvaMed, the Medtech Association, released the following statements from President and CEO Scott Whitaker and Zach Rothstein, Executive Director of AdvaMedDx, on FDA’s final rule for Laboratory Developed Tests (LDTs):
BioLab Sciences Celebrates 6 Year Anniversary and Cuts the Ribbon on New Facility in Mesa
BioLab Sciences, an Arizona life science company with a mission to manufacture reliable and safe products with the highest quality to help optimize body performance through continuous innovation, education, superior customer service, and teamwork celebrated its 6th anniversary as it cut the ribbon on its new manufacturing facility in Mesa, Arizona.Continue reading
Medtronic Celebrates 75 Years of Life Saving Innovations
Over 75 years, Medtronic has reinvented what’s possible for the world. The Medtronic Mission has fueled each step to alleviate pain, restore health, and extend life.
Continue reading
Inside Arizona Incubators and Accelerators
Join us for an enlightening discussion on maximizing your potential with in-state incubators, featuring an esteemed panel from across the state of Arizona. Panelists include Anita Bell from the University of Arizona Center for Innovation (UACI), Tom Schumann from the Center for Entrepreneurial Innovation (CEI) and Russ Yelton from Yelton and Associates. Discover how these incubators serve as fertile grounds for growth and innovation, providing invaluable support, mentorship, and resources tailored specifically to the needs of budding life science startups. Learn how strategically positioning your company within these incubators can facilitate access to crucial networks, funding opportunities, and specialized expertise.Continue reading
Patient Celebrates 10 Years Since SynCardia’s Total Artificial Heart
SynCardia Systems, LLC., a Picard Medical Company, proudly commemorates Steve William’s remarkable 10-year journey since receiving a SynCardia Total Artificial Heart (STAH). Steve underwent the STAH implantation procedure on April 17, 2014.Continue reading
FTC Announces Rule Banning Noncompetes (Press Release)
FTC’s final rule will generate over 8,500 new businesses each year, raise worker wages, lower health care costs, and boost innovationContinue reading
Arizona bioscience growth continues, sets record highs
PHOENIX–Arizona’s bioscience sector has continued its sustained advancement over the past two years and established record highs for several performance metrics, at growth rates often outpacing the nation, according to the latest data analysis commissioned by the Flinn Foundation.
Arizona reached record highs in National Institutes of Health funding, bioscience jobs and wages, university research and development, and certain measures of university technology-transfer, as well as an increase in venture capital funding.
Since the launch of Arizona’s Bioscience Roadmap in 2002, performance metrics have been tracked and shared publicly by a third-party consultant. The latest analysis by TEConomy Partners released April 22 is the first since 2022.
“Arizona’s bioscience community—researchers, entrepreneurs, investors, educators, hospitals, companies, and more—has accomplished so much since the beginning of the Roadmap,” said Tammy McLeod, Ph.D., Flinn Foundation president and CEO. “The upward trajectory of metrics like new bioscience jobs and university research shows the power of collaboration across the community. And it illustrates why the Flinn Foundation is intent on renewing the Roadmap, our state’s strategic plan to enhance health outcomes and economic prospects.”Continue reading
Arizona’s Life Science Sector is Rising Up
Arizona’s life science community gathered at Langham Logistics in Phoenix on April 18, 2024. Attendees toured this state-of- the-art facility that serves the needs of the West Coast’s GMP and pharmaceutical industries, made connections, and learned how they can get engaged in accelerating the growth of Arizona’s life science sector.Continue reading
Barrow Neurological selected as the inaugural site for the Neuralink PRIME Study
The first participant in Neuralink’s PRIME Study recently demonstrated the ability to use brain activity to command an external device. The successful procedure for Neuralink’s N1 Implant was performed earlier this year at Barrow Neurological Institute, located in Phoenix, Arizona. Neuralink calls this early, encouraging step a significant milestone for its wireless brain-computer interface (BCI) and, importantly, for adults with quadriplegia due to ALS or spinal cord injury.Continue reading